BACKGROUND: It is necessary to potentiate the immune system of fishes against stresses in farms. OBJECTIVES: This study was carried out to address the potential effect of Levamisole on immune system of rainbow trout against density stress. METHODS: 1500 fish (average weight of 50 g) were divided into 5 test groups, in which each test group was repeated three times with average density of 33 kg/m3. They were fed with commercial diet supplemented with Levamisole at concentrations of 0 (control), 100, 250, 500 and 1000 mg / kg for a period of 45 days. The fishes of all groups were then fed with Levamisole free diet and exposed to 2 and 3-fold density stress for the following 15 days. Blood samples were collected on days 0, 15, 30, 45 and 60 to evaluate the serum compliment and lysozyme activity as well as total immunoglobulins. RESULTS: The results showed that all used concentrations of Levamisole just had significant effect on compliment activity after 45 days feeding period (p<0.05). Higher levels of lysozyme and complement activity as well as total immunoglobulin were observed in 1000 mg/kg Levamisole treated group when exposed to density stresses 2 and 3-fold at the end of trial (day 60) (p<0.05). The highest overall survival was found in group which was treated with 1000 mg/kg of Levamisole. CONCLUSIONS: Our results revealed that using 0/1% Levamisole as an immunostimulator in commercial diet could potentiate rainbow trout against outbreak of high density stresses and increase its overall survival.

Gastrointestinal nematodes pose a threat to animal health and affect farmers by negatively impacting farm management.

The control of gastrointestinal nematodes (GINs) in small ruminants is principally dependent on anthelmintic therapy, which encounters the rising problem of anthelmintic resistance (AR) development. Veterinarians reported anthelmintic failure in several sheep farms in Arbat District, Sulaymaniyah, northern Iraq, which called for a systematic study about the efficacy of three commonly used drugs: albendazole, ivermectin, and levamisole.

A female Ongole calf aged one year and nine months was found to have nodular development around the left eye and neck region. Clinical examination revealed that the calf had cutaneous papilloma (wart), which was treated with autohemotherapy, ivermectin and levamisole injections along with placement of a ligature around wart's base. On the third day of treatment, a large papilloma on the left lower eyelid dried up and sloughed off. On the tenth day of therapy, the warts on the upper eyelid and neck began to dry and flake off, leaving behind barely visible scars at the original growth sites. The animal underwent an uncomplicated recovery and completely recovered from the ailment.

Since there is no registered anthelmintic drug available for use in goats, extra-label use of drugs is a common practice in most countries. The aim of the present study was to compare the pharmacokinetic disposition of levamisole (LVM)-oxyclozanide (OXZ) combination in sheep and goats following per os administration. Goats (n = 8) and sheep (n = 8) 12- to 16-months-old were used for this study. The animals received tablet formulation of LVM and OXZ combination orally at a dose of 7.5 mg/kg and 15 mg/kg body weight, respectively. Blood samples were collected by jugular vein at different times between 5 min and 120 h after drug administrations. The plasma concentrations of LVM and OXZ were analyzed by HPLC following liquid-liquid phase extraction procedures. The plasma concentrations and systemic availabilities of both LVM and OXZ in goats were lower and the plasma persistence of LVM was shorter compared with those observed in sheep. Terminal half-lives (t1/2λz) of both molecules are shorter in goats compared with those in sheep. Goats treated with LVM-OXZ combination at the recommended dose for sheep may result in a reduced efficacy, because of under-dosing, which may increase the risk of drug resistance in parasites. Increased or repeated dose could be a strategy to provide higher plasma concentration and thus to improve the efficacy against the target parasites in goats compared with sheep. However, some adverse reactions may occur since LVM has relatively very narrow therapeutic index due to its nicotine-like structure and effect.

Experimental Trichinella zimbabwensis infections were established in three baboons (Papio sp.) and four vervet monkeys (Cercopithecus aethiops) and the clinical-pathological manifestations assessed. The infected animals showed clinical signs ranging from fever, diarrhoea, periorbital oedema and muscular pain in varying degrees. One baboon became blind due to the infection. Levels of creatinine phosphokinase and lactate dehydrogenase increased to reach a peak on Day 42 post-infection (pi) for both baboons and monkeys. Blood parameters such as packed cell volume, levels of red blood cells and white blood cells did not change significantly from the normal ranges except for the levels of eosinophils which peaked above the normal ranges at Day 28 and 56 pi in baboons and at Day 56 pi in monkeys. Two baboons and two monkeys died during the course of the experiment. They were emaciated and showed lesions such as ascites, hydropericardium, congested liver and enlarged gall bladder. Histopathological findings of various muscles included a basophilic transformation of muscle cells, the disappearance of sarcomere myofibrils and basophilic sarcoplasm with the presence of Trichinella larvae in the sarcoplasm. These changes were mainly in the massetter and were of various intensities in the tail, gastrocnemius and biceps muscles. Five consecutive treatments with an oxfendazole-levamisole combination on surviving animals failed to clear the infection whereas ivermectin cleared the infection after one treatment in two monkeys and after two treatments in a baboon.

We studied the antibody responses to transmissible gastroenteritis (TGE) in serum, colostrum, and milk from sows vaccinated with 2 attenuated (1 IM and 1 oral-IM) and 1 nonattenuated live vaccines and the relationship of these responses with the survivability of the sow's suckling pigs after challenge exposure with virulent TGE virus. Contrary to previous studies, the anti-TGE virus-neutralizing geometric mean titers (GMT) in the milk of sows vaccinated with attenuated vaccines at 3 and 5 days of lactation were similar to that found in the colostrum. Colostral and serum antibody titers were highest in sows given 2 injections of the IM attenuated vaccine. Half of the sows given the oral-IM attenuated vaccine did not seroconvert after 2 oral doses. Only sows vaccinated with the nonattenuated live vaccine had milk GMT that remained high for 21 days after farrowing. The linear relationship between colostral GMT and percentage of survivability of suckling pigs challenge exposed at 3 days of age was significant (P less than 0.05), although the relationship between serum GMT and percentage of survivability and the relationship between milk GMT and percentage of survivability were not significant (P greater than 0.10). The linear relationship between colostral (P less than 0.10) or pre-challenge exposure milk (P less than 0.05) GMT and percentage of survivability of suckling pigs challenge exposed at 5 days of age was significant. We have no adequate explanation for the relatively low colostral GMT, the relatively high milk GMT at 3 and 5 days of lactation in vaccinated sows, or the lack of significant linear relationship between milk GMT and survivability of pigs challenge exposed at 3 days of age.

mature Ostertagia ostertagi and immature Ostertagia spp. in naturally infected dairy calves, activity of levamisole; overwinter survival on pasture of gastrointestinal helminth free-living stages as found in necropsy of previously helminth free calves placed on pasture in April: Kentucky

levamisole toxicity in pigs was enhanced by nicotine-like compound (pyrantel) but was not affected by organophosphate (dichlorvos)

Ostertagia ostertagi, beef calves (exper.), levamisole gel formulation evaluated for efficacy, safety, and residues